Dr. Reddy is a principal investigator in the ongoing SynerFuse feasibility study, according to a May 15 news release shared with Becker’s. He and Dr. Falowski are also strategic advisors to the company.
SynerFuse develops devices to address back pain associated with spinal fusion.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
